Biomea Fusion, Inc. is a biopharmaceutical company dedicated to developing innovative therapeutics for patients with serious medical needs. Operating in the US, the mission of Biomea Fusion revolves around fighting diseases through scientific discovery.
Biomea functions within the healthcare sector, particularly specialised in biopharmaceuticals. Its primary service is creating novel treatments with covalent small molecules. It operates independently, continually working on new therapies that could find a permanent place within the medical industry.
Monitor the BMEA share price by adding it to your eToro watchlist.